Established in 1891, the Washington State Pharmacy Quality Assurance Commission (WA Pharmacy Commission) regulates the practice of pharmacy, and the distribution, manufacturing, and delivery of pharmaceuticals within and into the state. The commission protects and promotes public health and safety by issuing licenses, registrations, and certifications to qualified persons and entities and responding to complaints or reports of unprofessional conduct. The Commission is assigned the authority to enforce and change the schedule of controlled substances in Washington state.
Washington State Pharmacy Quality Assurance Commission
(WA Pharmacy Commission)
Public
Structural Relationships
-
-
Washington State Pharmacy Quality Assurance Commission
(WA Pharmacy Commission)
WA Pharmacy Commission - Information Set
- No information available at this time
Observations
The Week Ahead
(January 17, 2022)
Washington State House and Senate policy committees had full schedules for the second week of the short session as 21 cannabis-related bills vied for legislator attention - including four newly introduced.
The Week Ahead
(August 30, 2021)
- USA - Washington
- Washington State Governor's Interagency Council on Health Disparities (WA Governor Council on Health Disparities)
The Governor’s Council on Health Disparities planned to convene for the first time since December 2020 as policymaker attention began focusing on the 2022 legislative session.
WSLCB - Board Caucus
(April 27, 2021) - Delta-8-THC
The day before releasing a policy statement on delta-8-THC and other derived cannabinoids, board and staff discussed their work amidst often anecdotal input from stakeholders.
WA Pharmacy Commission - Public Meeting
(April 23, 2021) - Interpretation of THC Statute
At the request of WSLCB and with some hedging after hearing from stakeholders, the Pharmacy Commission affirmed a “plain language reading” of the controlled substances act definition of ‘THC’.
WSLCB - Board Caucus
(May 4, 2021) - Delta-8-THC
Policy and Rules Manager Kathy Hoffman walked the board through the past, present, and future of WSLCB regulation of cannabinoids aside from delta-9-THC in legal cannabis products.
WSLCB - Board Meeting
(April 28, 2021) - Summary
The Board proposed rules to double tier 1 producer canopy and heard comments calling for incentivized medical cannabis production and regulation of delta-8-THC.
WA House PS - Committee Meeting
(February 12, 2021) - HB 1499 - Public Hearing
Legislation representing the first effort in Washington state for broad decriminalization of personal possession of controlled substances including enhanced treatment and recovery services brought out the support of hundreds - and opposition from just ten people.
The Week Ahead
(February 8, 2021)
Of 19 bills closely tracked, five were out of committee and seven were scheduled for action this week - including new bills to limit cannabis concentrates and a drug decriminalization bill.
The Week Ahead
(January 18, 2021)
Three new cannabis bills were introduced and four were scheduled for activity while the Washington Pharmacy Quality Assurance Commission considered regulation of Epidiolex.